Ad is loading...
FSPTX
Price
$37.28
Change
-$0.91 (-2.38%)
Updated
Nov 15 closing price
PTTEX
Price
$77.24
Change
-$1.94 (-2.45%)
Updated
Nov 15 closing price
Ad is loading...

FSPTX vs PTTEX

Header iconFSPTX vs PTTEX Comparison
Open Charts FSPTX vs PTTEXBanner chart's image
Fidelity Select Technology
Price$37.28
Change-$0.91 (-2.38%)
VolumeN/A
CapitalizationN/A
Putnam Global Technology R6
Price$77.24
Change-$1.94 (-2.45%)
VolumeN/A
CapitalizationN/A
FSPTX vs PTTEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPTX vs. PTTEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPTX is a StrongSell and PTTEX is a StrongSell.

FUNDAMENTALS
Fundamentals
FSPTX has more cash in the bank: 16B vs. PTTEX (1.34B). PTTEX pays higher dividends than FSPTX: PTTEX (0.58) vs FSPTX (0.01). FSPTX was incepted earlier than PTTEX: FSPTX (43 years) vs PTTEX (6 years). PTTEX is a more actively managed with annual turnover of: 57.00 vs. FSPTX (24.00). FSPTX (0) and PTTEX (0) have matching initial minimum investment requirements. FSPTX annual gain was more profitable for investors over the last year : 38.90 vs. PTTEX (32.96). FSPTX (94.46) and PTTEX (91.83) have equivalent 5 years return.
FSPTXPTTEXFSPTX / PTTEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence43 years6 years-
Gain YTD30.76127.019114%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets16B1.34B1,190%
Annual Yield % from dividends0.010.582%
Returns for 1 year38.9032.96118%
Returns for 3 years16.841.93874%
Returns for 5 years94.4691.83103%
Returns for 10 years200.26N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYE11.70-0.03
-0.26%
Myers Industries
EXPE181.35-0.91
-0.50%
Expedia Group
ATS28.14-0.62
-2.16%
ATS Corp
INBX13.83-0.50
-3.49%
Inhibrx Biosciences Inc.
NERV2.20-0.12
-5.17%
Minerva Neurosciences